1 min read

Cleerly's AI scans comparable to gold-standard angiography

Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name.

By Andrea Park

The newly published results of a study show that the New York City-based startup’s artificial intelligence-powered software does, indeed, allow healthcare providers to (ahem) clearly spot signs of heart disease without requiring the invasive evaluations that make up the current gold standard for coronary artery disease diagnosis.

In the latter method, the coronary angiogram, a catheter is threaded through the arm or leg to reach the heart, where it injects dye into its arteries so X-ray images can capture how blood flows through the vessels. Though serious complications from the procedure are rare, they potentially include injury to the catheterized artery, an allergic reaction or kidney damage from the dye, as well as heart attack, stroke and more. Read the full article HERE.

Cleerly's AI scans comparable to gold-standard angiography

Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name.

Read More

Cleerly Takes Precision Heart Care to the Next Level | Dicardiology

Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease. 

Read More

Cleerly’s Technology | An Important Impact On Our Overall Wellness

Health Tech: Dr James Min On How Cleerly’s Technology Can Make An Important Impact On Our Overall Wellness

Read More